Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
10 p, 285.5 KB Pimecrolimus in atopic dermatitis : Consensus on safety and the need to allow use in infants / Luger, Thomas (University of Münster. Department of Dermatology) ; Boguniewicz, Mark (Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine) ; Carr, Warner (Southern California Research) ; Cork, Michael (Academic Unit of Dermatology Research, Department of Infection and Immunity, The University of Sheffield, K Floor, The Medical School (RHH Tower)) ; Deleuran, Mette (Department of Dermatology, Aarhus University Hospital) ; Eichenfield, Lawrence (Departments of Pediatrics and Medicine, University of California, San Diego School of Medicine, Rady Children's Hospital) ; Eigenmann, Philippe (Pediatric Allergy Unit, Children's University Hospital) ; Fölster-Holst, Regina (Department of Dermatology, University Clinics of Schleswig-Holstein) ; Gelmetti, Carlo (Department of Pathophysiology and Transplantation, University of Milan, Clinica Dermatologica, Fondazione I.R.C.C.S. Ca' Granda "Ospedale Maggiore Policlinico") ; Gollnick, Harald (Department of Dermatology & Venereology, Otto-von-Guericke University of Magdeburg) ; Hamelmann, Eckard (Allergy Center Ruhr, Ruhr-University Bochum, & Evangelisches Krankenhaus Bielefeld, Klinik für Kinder und Jugendmedizin) ; Hebert, Adelaide A (Departments of Dermatology and Pediatrics, The University of Texas Medical School-Houston) ; Muraro, Antonella (Food Allergy Referral Centre, Department of Woman and Child Health, University Hospital of Padua) ; Oranje, Arnold P (Intermedica Dermatology and Hair Clinic) ; Paller, Amy S (Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine) ; Paul, Carle (Dermatology Department, INSERM 1056, Paul Sabatier University, Larrey Hospital) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Ring, Johannes (Department of Dermatology and Allergology Biederstein, Christine Kühne-Center for Allergy Research and Education, Technische Universität München) ; Siegfried, Elaine (Departments of Pediatrics and Dermatology, Saint Louis University School of Medicine) ; Spergel, Jonathan M (Division of Allergy and Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania) ; Stingl, Georg (Department of Dermatology, Medical University of Vienna) ; Taieb, Alain (Service de Dermatologie et Dermatologie Pédiatrique Centre de référence pour les maladies rares de la peau, INSERM 1035, Université de Bordeaux) ; Torrelo, Antonio (Department of Dermatology, Hospital Niño Jesus) ; Werfel, Thomas (Department of Dermatology and Allergy, Hannover Medical School) ; Wahn, Ulrich (Department of Pediatric Pneumology and Immunology, Charite) ; Universitat Autònoma de Barcelona
Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds. [...]
2015 - 10.1111/pai.12331
Pediatric Allergy and Immunology, Vol. 26 (april 2015) , p. 306-315  

Vea también: autores con nombres similares
1 Paul, C.
1 Paul, C.R.C
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.